Publication | Open Access
Down-Regulation of SIX3 is Associated with Clinical Outcome in Lung Adenocarcinoma
30
Citations
29
References
2013
Year
SIX3 may play an important role as a novel suppressor in human lung cancer. SIX3 has potential as a novel prognostic biomarker for patients with lung adenocarcinomas.
| Year | Citations | |
|---|---|---|
Page 1
Page 1